(Q33320727)

English

Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

based on heuristic

inferred from title

foot-and-mouth disease

1 reference

based on heuristic

inferred from title

foot-and-mouth disease virus

object named as

foot-and-mouth disease virus

1 reference

based on heuristic

inferred from title

author name string

Z J Ren

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

C J Tian

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Q S Zhu

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M Y Zhao

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A G Xin

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

W X Nie

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

S R Ling

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M W Zhu

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

J Y Wu

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

H Y Lan

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Y C Cao

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Y Z Bi

12

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

24 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1471-1481

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Transmission of foot-and-mouth disease by vaccinated cattle following natural challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Control and eradication of foot-and-mouth disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Cloned Viral Protein Vaccine for Foot-and-Mouth Disease: Responses in Cattle and Swine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Using Genetically Engineered Bacteria for Vaccine Production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Protection of cattle against foot-and-mouth disease by a synthetic peptide.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Effective synthetic peptide vaccine for foot-and-mouth disease in swine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Cloning of cDNA of major antigen of foot and mouth disease virus and expression in E. coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Protective immune response of the capsid precursor polypeptide (P1) of foot and mouth disease virus type 'O' produced in Pichia pastoris

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Molecular organization of the shell of the Teven bacteriophage head

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

The two dispensable structural proteins (soc and hoc) of the T4 phage capsid; their purification and properties, isolation and characterization of the defective mutants, and their binding with the defective heads in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Molecular architecture of bacteriophage T4 capsid: vertex structure and bimodal binding of the stabilizing accessory protein, Soc.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Molecular architecture of the prolate head of bacteriophage T4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Bacteriophage T4 nanoparticle capsid surface SOC and HOC bipartite display with enhanced classical swine fever virus immunogenicity: a powerful immunological approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Phage display of intact domains at high copy number: a system based on SOC, the small outer capsid protein of bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Cloning of linear DNAs in vivo by overexpressed T4 DNA ligase: construction of a T4 phage hoc gene display vector.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Phage T4 SOC and HOC display of biologically active, full-length proteins on the viral capsid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

A bipartite bacteriophage T4 SOC and HOC randomized peptide display library: detection and analysis of phage T4 terminase (gp17) and late sigma factor (gp55) interaction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Vaccination against very virulent infectious bursal disease virus using recombinant T4 bacteriophage displaying viral protein VP2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Nucleotide sequence and genome organization of foot-and-mouth disease virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Reconstitution of immunosuppressed mice with mononuclear cells from donors sensitized to foot-and- mouth disease virus (FMDV)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Structure of the FMDV translation initiation site and of the structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Comparison and analysis of the complete nucleotide sequence of foot-and-mouth disease viruses from animals in Korea and other PanAsia strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Multicomponent anthrax toxin display and delivery using bacteriophage T4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.053

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.12.053

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33320727&oldid=1958178706"